Clinical trials
Phase 2 Recurrence trials in Norway
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
13 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2005 | 1 |
| 2007 | 1 |
| 2013 | 1 |
| 2014 | 1 |
| 2015 | 3 |
| 2016 | 1 |
| 2018 | 2 |
| 2020 | 2 |
| 2022 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 9 |
| Unknown status | 3 |
| Recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Novartis Pharmaceuticals | 3 |
| Merck Sharp & Dohme LLC | 2 |
| Aarhus University Hospital | 1 |
| Amsterdam UMC, location VUmc | 1 |
| Henrik Gregersen | 1 |
| Medical University of Vienna | 1 |
| Nordic Myeloma Study Group | 1 |
| Norwegian University of Science and Technology | 1 |
| Nykode Therapeutics ASA | 1 |
| pharmaand GmbH | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Recurrence | 13 |
| Multiple Myeloma | 3 |
| Lymphoma, Large B-Cell, Diffuse | 2 |
| Neoplasm Metastasis | 2 |
| Cluster Headache | 1 |
| Ependymoma | 1 |
| Leukemia | 1 |
| Leukemia, Myeloid, Acute | 1 |
| Lymphoma, Follicular | 1 |
| Medulloblastoma | 1 |
Trials
Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.